Computers join the battle against novel coronavirus

NewsGuard 100/100 Score

Scientists everywhere are banding together to fight the novel coronavirus, and they're already making progress. Computational chemists are focused on building computer models of the virus's parts, which could aid in developing new therapeutics. Now, organizations around the world are offering up their computing power to researchers to help provide rapid results, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

Building an accurate model of SARS-CoV-2, the virus that causes the COVID-19 illness, requires a significant amount of computing power. This is especially true if scientists want fast results from their simulations, which is a given under current circumstances, writes Assistant Editor Sam Lemonick. In the U.S., a group of universities, national labs and corporations have formed a consortium offering free computing resources to researchers, including Google's and Amazon's extensive cloud services and some of the world's most powerful supercomputers. Similar efforts are underway in Europe, China and elsewhere, with the goal of providing rapid resources for an ever-evolving situation.

To take advantage of these resources, researchers submit proposals to the consortia, which are then fast-tracked for approval. Although many scientists who request computing resources are familiar with these technologies, the U.S. and E.U. consortia plan to assist those who aren't by matching them with expert collaborators. Current projects include a study on protein inhibitors of viral enzymes that could prevent SARS-CoV-2 from replicating, using powerful supercomputers from Oak Ridge National Laboratory. The consortia are looking for scientists in a broad range of dis ciplines to use these computer systems for fighting COVID-19. Researchers are encouraged to keep submitting proposals, with the hope that the sense of urgency will lead to real progress in the near future.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses